TY - JOUR
T1 - Prevalence of dry eye syndrome in an adult population
AU - Hashemi, Hassan
AU - Khabazkhoob, Mehdi
AU - Kheirkhah, Ahmad
AU - Emamian, Mohammad Hassan
AU - Mehravaran, Shiva
AU - Shariati, Mohammad
AU - Fotouhi, Akbar
PY - 2014/4
Y1 - 2014/4
N2 - Background: To determine the prevalence of dry eye syndrome in the general 40- to 64-year-old population of Shahroud, Iran. Design: Population-based cross-sectional study. Participants: Through cluster sampling, 6311 people were selected and 5190 participated. Assessment of dry eye was done in a random subsample of 1008 people. Methods: Subjective assessment for dry eye syndrome was performed using Ocular Surface Disease Index questionnaire. In addition, the following objective tests of dry eye syndrome were employed: Schirmer test, tear break-up time, and fluorescein and Rose Bengal staining using the Oxford grading scheme. Main Outcome Measures: Those with an Ocular Surface Disease Index score ≥23 were considered symptomatic, and dry eye syndrome was defined as having symptoms and at least one positive objective sign. Results: The prevalence of dry eye syndrome was 8.7% (95% confidence interval 6.9-10.6). Assessment of signs showed an abnormal Schirmer score in 17.8% (95% confidence interval 15.5-20.0), tear break-up time in 34.2% (95% confidence interval 29.5-38.8), corneal fluorescein staining (≥1) in 11.3% (95% confidence interval 8.5-14.1) and Rose Bengal staining (≥3 for cornea and/or conjunctiva) in 4.9% (95% confidence interval 3.4-6.5). According to the Ocular Surface Disease Index scores, 18.3% (95% confidence interval 15.9-20.6) had dry eye syndrome symptoms. The prevalence of dry eye syndrome was significantly higher in women (P=0.010) and not significantly associated with age (P=0.291). The objective dry eye syndrome signs significantly increased with age. Conclusions: Based on the findings, the prevalence of dry eye syndrome in the studied population is in the mid-range. The prevalence is higher in women. Also, objective tests tend to turn abnormal at higher age. Pterygium is associated with dry eye syndrome and increased its symptoms.
AB - Background: To determine the prevalence of dry eye syndrome in the general 40- to 64-year-old population of Shahroud, Iran. Design: Population-based cross-sectional study. Participants: Through cluster sampling, 6311 people were selected and 5190 participated. Assessment of dry eye was done in a random subsample of 1008 people. Methods: Subjective assessment for dry eye syndrome was performed using Ocular Surface Disease Index questionnaire. In addition, the following objective tests of dry eye syndrome were employed: Schirmer test, tear break-up time, and fluorescein and Rose Bengal staining using the Oxford grading scheme. Main Outcome Measures: Those with an Ocular Surface Disease Index score ≥23 were considered symptomatic, and dry eye syndrome was defined as having symptoms and at least one positive objective sign. Results: The prevalence of dry eye syndrome was 8.7% (95% confidence interval 6.9-10.6). Assessment of signs showed an abnormal Schirmer score in 17.8% (95% confidence interval 15.5-20.0), tear break-up time in 34.2% (95% confidence interval 29.5-38.8), corneal fluorescein staining (≥1) in 11.3% (95% confidence interval 8.5-14.1) and Rose Bengal staining (≥3 for cornea and/or conjunctiva) in 4.9% (95% confidence interval 3.4-6.5). According to the Ocular Surface Disease Index scores, 18.3% (95% confidence interval 15.9-20.6) had dry eye syndrome symptoms. The prevalence of dry eye syndrome was significantly higher in women (P=0.010) and not significantly associated with age (P=0.291). The objective dry eye syndrome signs significantly increased with age. Conclusions: Based on the findings, the prevalence of dry eye syndrome in the studied population is in the mid-range. The prevalence is higher in women. Also, objective tests tend to turn abnormal at higher age. Pterygium is associated with dry eye syndrome and increased its symptoms.
KW - Dry eye
KW - Iran
KW - Population-based study
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=84899074515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899074515&partnerID=8YFLogxK
U2 - 10.1111/ceo.12183
DO - 10.1111/ceo.12183
M3 - Article
C2 - 23927383
AN - SCOPUS:84899074515
SN - 1442-6404
VL - 42
SP - 242
EP - 248
JO - Clinical and Experimental Ophthalmology
JF - Clinical and Experimental Ophthalmology
IS - 3
ER -